Εμφανίζονται 1 - 16 Αποτελέσματα από 16 για την αναζήτηση 'Samuel D Rabkin', χρόνος αναζήτησης: 1,12δλ Περιορισμός αποτελεσμάτων
  1. 1
    Designing herpes viruses as oncolytics

    Designing herpes viruses as oncolytics ανά Cole Peters, Samuel D Rabkin

    Έκδοση 2015-01-01
    Λήψη πλήρους κειμένου
    Άρθρο
  2. 2
    Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells

    Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells ανά Kimia Kardani, Judit Sanchez Gil, Samuel D. Rabkin

    Έκδοση 2023-05-01
    Λήψη πλήρους κειμένου
    Άρθρο
  3. 3
    Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma

    Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma ανά Dipongkor Saha, Samuel D Rabkin, Robert L Martuza

    Έκδοση 2020-05-01
    Λήψη πλήρους κειμένου
    Άρθρο
  4. 4
    Triple threat to cancer: rationale for combining oncolytic viruses, MEK inhibitors, and immune checkpoint blockade

    Triple threat to cancer: rationale for combining oncolytic viruses, MEK inhibitors, and immune checkpoint blockade ανά Praveen K. Bommareddy, Samuel D. Rabkin, Howard L. Kaufman

    Έκδοση 2019-04-01
    Λήψη πλήρους κειμένου
    Άρθρο
  5. 5
    Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma

    Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma ανά Ali Chahlavi, Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin

    Έκδοση 1999-06-01
    Λήψη πλήρους κειμένου
    Άρθρο
  6. 6
    In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV

    In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV ανά Nusrat Jahan, Shanawaz M. Ghouse, Robert L. Martuza, Samuel D. Rabkin

    Έκδοση 2021-08-01
    Λήψη πλήρους κειμένου
    Άρθρο
  7. 7
    Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma

    Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma ανά Praveen K. Bommareddy, Andrew Zloza, Samuel D. Rabkin, Howard L. Kaufman

    Έκδοση 2019-07-01
    Λήψη πλήρους κειμένου
    Άρθρο
  8. 8
    Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival

    Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival ανά Howard L Kaufman, Dipongkor Saha, Samuel D Rabkin, Robert L Martuza, Praveen K Bommareddy, Hiroaki Wakimoto

    Έκδοση 2024-04-01
    Λήψη πλήρους κειμένου
    Άρθρο
  9. 9
    Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?

    Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy? ανά Howard L Kaufman, Hongbin Wang, Dipongkor Saha, Samuel D Rabkin, Mia Borlongan, Uyen Le, Hans J Nauwynck

    Έκδοση 2024-05-01
    Λήψη πλήρους κειμένου
    Άρθρο
  10. 10
    Ionizing Radiation Does Not Alter the Antitumor Activity of Herpes Simplex Virus Vector G207 in Subcutaneous Tumor Models of Human and Murine Prostate Cancer

    Ionizing Radiation Does Not Alter the Antitumor Activity of Herpes Simplex Virus Vector G207 in Subcutaneous Tumor Models of Human and Murine Prostate Cancer ανά Timothy J. Jorgensen, Sanford Katz, Ellen K. Wittmack, Susan Varghese, Tomoki Todo, Samuel D. Rabkin, Robert L. Martuza

    Έκδοση 2001-01-01
    Λήψη πλήρους κειμένου
    Άρθρο
  11. 11
    Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells

    Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells ανά Lei Wang, Jianfang Ning, Hiroaki Wakimoto, Shulin Wu, Chin-lee Wu, Melissa R. Humphrey, Samuel D. Rabkin, Robert L. Martuza

    Έκδοση 2019-06-01
    Λήψη πλήρους κειμένου
    Άρθρο
  12. 12
    Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models

    Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models ανά Wei Zhang, Giulia Fulci, Hiroaki Wakimoto, Tooba A. Cheema, Jason S. Buhrman, Deva S. Jeyaretna, Anat O. Stemmer Rachamimov, Samuel D. Rabkin, Robert L. Martuza

    Έκδοση 2013-06-01
    Λήψη πλήρους κειμένου
    Άρθρο
  13. 13
    Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma

    Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma ανά Jian-Fang Ning, Monica Stanciu, Melissa R. Humphrey, Joshua Gorham, Hiroko Wakimoto, Reiko Nishihara, Jacqueline Lees, Lee Zou, Robert L. Martuza, Hiroaki Wakimoto, Samuel D. Rabkin

    Έκδοση 2019-07-01
    Λήψη πλήρους κειμένου
    Άρθρο
  14. 14
    Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma

    Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma ανά Ming Li, Guoping Li, Juri Kiyokawa, Zain Tirmizi, Leland G. Richardson, Jianfang Ning, Saumya Das, Robert L. Martuza, Anat Stemmer-Rachamimov, Samuel D. Rabkin, Hiroaki Wakimoto

    Έκδοση 2020-12-01
    Λήψη πλήρους κειμένου
    Άρθρο
  15. 15
    An Aberrant Transcription Factor Network Essential for Wnt Signaling and Stem Cell Maintenance in Glioblastoma

    An Aberrant Transcription Factor Network Essential for Wnt Signaling and Stem Cell Maintenance in Glioblastoma ανά Esther Rheinbay, Mario L. Suvà, Shawn M. Gillespie, Hiroaki Wakimoto, Anoop P. Patel, Mohammad Shahid, Ozgur Oksuz, Samuel D. Rabkin, Robert L. Martuza, Miguel N. Rivera, David N. Louis, Simon Kasif, Andrew S. Chi, Bradley E. Bernstein

    Έκδοση 2013-05-01
    Λήψη πλήρους κειμένου
    Άρθρο
  16. 16
    A high-throughput screening and computation platform for identifying synthetic promoters with enhanced cell-state specificity (SPECS)

    A high-throughput screening and computation platform for identifying synthetic promoters with enhanced cell-state specificity (SPECS) ανά Ming-Ru Wu, Lior Nissim, Doron Stupp, Erez Pery, Adina Binder-Nissim, Karen Weisinger, Casper Enghuus, Sebastian R. Palacios, Melissa Humphrey, Zhizhuo Zhang, Eva Maria Novoa, Manolis Kellis, Ron Weiss, Samuel D. Rabkin, Yuval Tabach, Timothy K. Lu

    Έκδοση 2019-06-01
    Λήψη πλήρους κειμένου
    Άρθρο

Εργαλεία αναζήτησης: